ForViva (LON:FVA – Get Free Report)‘s stock had its “buy” rating restated by analysts at Canaccord Genuity Group in a research report issued on Wednesday, Digital Look reports. They presently have a GBX 190 price objective on the stock. Canaccord Genuity Group’s target price points to a potential upside of 31.03% from the company’s previous close.
Separately, Shore Capital Group reiterated a “hold” rating and set a GBX 135 price target on shares of ForViva in a report on Wednesday. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of GBX 162.50.
View Our Latest Stock Analysis on ForViva
ForViva Price Performance
Insider Activity at ForViva
In other ForViva news, insider Tim Jones acquired 40,000 shares of the company’s stock in a transaction dated Wednesday, July 15th. The shares were acquired at an average cost of GBX 137 per share, for a total transaction of £54,800. Insiders bought 90,000 shares of company stock valued at $12,380,000 in the last 90 days. Insiders own 7.31% of the company’s stock.
About ForViva
ForViva plc (LON: FVA) is a United Kingdom–based property company that operates in the residential and specialist housing sectors. The group’s activities are focused on ownership, management and leasing of housing assets that serve social, affordable and supported living needs. Its portfolio is oriented toward providing long‑term rental accommodation and specialist premises that accommodate people requiring additional care or support.
Services associated with ForViva’s property portfolio typically include day‑to‑day asset management, tenancy management, property maintenance and refurbishment, and collaboration with public sector bodies and third‑party care providers to deliver supported housing solutions.
See Also
- Five stocks we like better than ForViva
- Treasury Yields Haven’t Been This High Since 2007—3 ETFs to Watch
- 3 Healthcare Dividend Stocks Offering More Than Just Income
- AI Uncertainty Is Rising, But These 3 Chip ETFs Still Have Momentum
- Arhaus Has New Momentum—Could Other Furniture Stocks Be Next?
Receive News & Ratings for ForViva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ForViva and related companies with MarketBeat.com's FREE daily email newsletter.
